Recent NHS Digital data has shown that patient ratios vary widely across England, from 41,000 patients per GP at a practice in Coventry and Warwickshire, to just 96 at a Shropshire, Telford and Wrekin surgery.
This data shows worryingly large disparities in GP to patient ratios across the country and it is wholly unacceptable that patients should have to experience such variations in access to care.
NHSE/I has published a new policy for applications to the Medical Performers List (MPL), which introduces a number of changes including the removal of duplicated checks, introduction of more nuanced support tailored to the specific needs of the performer, and confirmation that performers are able to increase or decrease their scope of work whilst on the MPL.
The requirement to submit the FFT was suspended across the NHS in March 2020 to free up resources to support practices during the pandemic. The FFT has now restarted across the NHS and the temporary suspension will come to an end in March 2022. The requirement for practices to report to commissioners regarding FFT returns will be reintroduced into the GP contract from 1 April 2022.
Friends and Family Test (FFT) reporting to recommence 1st April 2022
NHS England has published guidance on the recommended vaccines and eligible cohorts for the 2022/23 seasonal flu vaccination programme.
The King’s Fund has published a major report on the ARRS, which focuses on four roles — social prescribing link workers; first contact physiotherapists; paramedics and pharmacists — to examine the issues related to the implementation of these roles, looking at the experiences of working in these roles and of the people managing them.
Kings Fund report on Additional Roles Reimbursement Scheme (ARRS)
Receive the latest updates from us and in real time on X (formerly Twitter) @SSTLMC. Retweets for interest; not necessarily endorsement.
The LMC office is open Monday to Thursday 9am to 5pm. We endeavour to respond to all enquiries within 5 working days. In the first instance, please use our Contact Us page.
You can also visit our CV19 page for the latest CV19 guidance.